Gujarat Kidney IPO Subscription Status
Gujarat Kidney IPO was subscribed over 2.69x on its Second day till 05.00 PM on 23rd December 2025.
- Gujarat Kidney IPO subscription QIB investors’ portion is 0.34x times, while NII subscribed 2.95x times, and RII investors subscribed 10.52x times.
- The company has received bids for 3,55,46,112 shares against 1,32,26,880 shares on offer on the Second day.
- Gujarat Kidney IPO was subscribed over 2.69x times on day 2.
- Gujarat Kidney IPO was subscribed over 1.52x times on day 1.
About the Gujarat Kidney IPO
Gujarat Kidney and Super Speciality Limited (GKASSL), founded in 2019, is one of the leading companies that provides multispeciality healthcare services. The company has multiple hospitals situated across Gujarat, India. Its main services include Secondary Care Services and Tertiary Care Services. Internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology are some of the medical care offered by the company.
The business runs 7 multispeciality hospitals and four pharmacies. Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand) are some of the hospitals operated by the company.
Gujarat Kidney IPO Company Financial Report
The company reported revenue of ₹40.40 crores in 2025 against ₹5.48 crores in 2024. The company reported a profit of ₹9.50 crores in 2025 against a profit of ₹1.71 crores in 2024.
Gujarat Kidney IPO GMP
Gujarat Kidney IPO GMP was ₹4 as of Tuesday, 23rd December. That indicates the IPO is trading at ₹118 with a ₹4 premium in the grey market against the issue price of ₹114.
